ArticleBiomedicines2026

Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy.

Şahin Bedir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.